Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
Clinical trial NCT05995899 · COMPLETED
Trial details
- NCT number
- NCT05995899
- Sponsor
- Kyle Staller, MD, MPH
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-06
- Primary completion
- 2025-12-17
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.